Acetylcholine affects the spatial scale of attention: evidence from Alzheimer's disease

Neuropsychology. 2000 Apr;14(2):288-98. doi: 10.1037//0894-4105.14.2.288.

Abstract

Location precues were used to manipulate the spatial scale of attention in visual search for a target in an array of letters in patients with dementia of the Alzheimer type (DAT) and in age-matched older controls. Cue size varied in the amount of spatial precision conferred. Scopolamine, a muscarinic antagonist, decreased overall arousal and broadened spatial attention after a precise precue (small and valid) to target location for DAT patients but not for controls, suggesting a selective effect for attentional impairment induced by cholinergic blockade. In contrast, physostigmine, a cholinesterase inhibitor, did not alter the distribution of spatial attention relative to no-drug baseline testing for patients. Results support a differential role for cholinergic mechanisms in the modulation of the spatial scale of visual attention.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcholine / metabolism*
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / psychology*
  • Arousal / drug effects
  • Attention / drug effects*
  • Case-Control Studies
  • Cholinergic Agents / pharmacology*
  • Cholinesterase Inhibitors / pharmacology
  • Cues
  • Female
  • Humans
  • Male
  • Middle Aged
  • Models, Neurological
  • Muscarinic Antagonists / pharmacology
  • Pattern Recognition, Visual / drug effects*
  • Physostigmine / pharmacology
  • Scopolamine / pharmacology
  • Space Perception / drug effects

Substances

  • Cholinergic Agents
  • Cholinesterase Inhibitors
  • Muscarinic Antagonists
  • Physostigmine
  • Scopolamine
  • Acetylcholine